{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:38:19Z","timestamp":1761896299263,"version":"3.37.3"},"reference-count":69,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T00:00:00Z","timestamp":1461196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Fondo de Investigaciones Sanitarias, Ministerio de Sanidad","award":["PI08\/1099"],"award-info":[{"award-number":["PI08\/1099"]}]},{"name":"Fondo de Investigaciones Sanitarias, Ministerio de Sanidad","award":["PI13\/01607"],"award-info":[{"award-number":["PI13\/01607"]}]},{"DOI":"10.13039\/501100009589","name":"Fundaci\u00f3n LAIR","doi-asserted-by":"crossref","award":["P160105"],"award-info":[{"award-number":["P160105"]}],"id":[{"id":"10.13039\/501100009589","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Caja de Navarra","award":["P22664"],"award-info":[{"award-number":["P22664"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0154159","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T18:11:43Z","timestamp":1461262303000},"page":"e0154159","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model"],"prefix":"10.1371","volume":"11","author":[{"given":"Nerea","family":"Rebolleda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Losada-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gema","family":"Perez-Chacon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raquel","family":"Castejon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Rosado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Morado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Teresa","family":"Vallejo-Cremades","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan A.","family":"Vargas-Nu\u00f1ez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4819-5890","authenticated-orcid":true,"given":"Paloma","family":"Perez-Aciego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,4,21]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1056\/NEJM200012143432402","article-title":"Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia","volume":"343","author":"KR Rai","year":"2000","journal-title":"N Engl J Med"},{"issue":"Suppl 7","key":"ref2","doi-asserted-by":"crossref","first-page":"vii154","DOI":"10.1093\/annonc\/mdq373","article-title":"Chronic lymphocytic leukemia","volume":"21","author":"M Hallek","year":"2010","journal-title":"Ann Oncol Off J Eur Soc Med Oncol ESMO"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.23979","article-title":"Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment","volume":"90","author":"M Hallek","year":"2015","journal-title":"Am J Hematol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1002\/cncr.24329","article-title":"Treatment of fludarabine-refractory chronic lymphocytic leukemia","volume":"115","author":"AM Tsimberidou","year":"2009","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hoc.2013.01.002","article-title":"Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications","volume":"27","author":"Y Herishanu","year":"2013","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1182\/blood.V97.9.2777","article-title":"Survivin is expressed on CD40 stimulation and interfaces proliferation and apoptosis in B-cell chronic lymphocytic leukemia","volume":"97","author":"L Granziero","year":"2001","journal-title":"Blood"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1182\/blood.V100.10.3749","article-title":"Tumor necrosis factor receptor-associated factor 1 gene overexpression in B-cell chronic lymphocytic leukemia: analysis of NF-\u03baB\/Rel\u2013regulated inhibitors of apoptosis","volume":"100","author":"G Munzert","year":"2002","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"HL Pahl","year":"1999","journal-title":"Oncogene"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/sj.leu.2404167","article-title":"DHMEQ, a new NF-kappaB inhibitor, induces apoptosis and enhances fludarabine effects on chronic lymphocytic leukemia cells","volume":"20","author":"R Horie","year":"2006","journal-title":"Leukemia"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1038\/leu.2014.96","article-title":"Targeting the proliferative and chemoresistant compartment in chronic lymphocytic leukemia by inhibiting survivin protein","volume":"28","author":"N Purroy","year":"2014","journal-title":"Leukemia"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1182\/blood-2010-05-284984","article-title":"The lymph node microenvironment promotes B-cell receptor signaling, NF-\u03baB activation, and tumor proliferation in chronic lymphocytic leukemia","volume":"117","author":"Y Herishanu","year":"2011","journal-title":"Blood"},{"key":"ref12","article-title":"The microenvironment in chronic lymphocytic leukemia (CLL) and other B cell malignancies: Insight into disease biology and new targeted therapies","author":"JA Burger","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"ref13","first-page":"1278","article-title":"Ibrutinib in relapsed chronic lymphocytic leukemia","volume":"369","author":"Byrd JC","year":"2013","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia","volume":"370","author":"RR Furman","year":"2014","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/ijc.10901","article-title":"Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice","volume":"104","author":"G Murillo","year":"2003","journal-title":"Int J Cancer"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1007\/s12185-009-0307-4","article-title":"Deguelin blocks cells survival signal pathways and induces apoptosis of HL-60 cells in vitro","volume":"89","author":"Y Chen","year":"2009","journal-title":"Int J Hematol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s12185-009-0311-8","article-title":"Involvement of SRC-3 in deguelin-induced apoptosis in Jurkat cells","volume":"89","author":"R Li","year":"2009","journal-title":"Int J Hematol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/jnci\/dji377","article-title":"Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis","volume":"97","author":"H-Y Lee","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1124\/mol.106.027367","article-title":"Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells","volume":"71","author":"X-H Peng","year":"2007","journal-title":"Mol Pharmacol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"10863","DOI":"10.1021\/jm301488q","article-title":"Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis","volume":"55","author":"D-J Chang","year":"2012","journal-title":"J Med Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/jnci\/djm007","article-title":"Structural basis for depletion of heat shock protein 90 client proteins by deguelin","volume":"99","author":"SH Oh","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1023\/B:APPT.0000031449.57551.e1","article-title":"Apoptosis induction by the natural product cancer chemopreventive agent deguelin is mediated through the inhibition of mitochondrial bioenergetics","volume":"9","author":"N Hail","year":"2004","journal-title":"Apoptosis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5612","DOI":"10.4049\/jimmunol.177.8.5612","article-title":"Deguelin, an Akt inhibitor, suppresses IkappaBalpha kinase activation leading to suppression of NF-kappaB-regulated gene expression, potentiation of apoptosis, and inhibition of cellular invasion","volume":"177","author":"AS Nair","year":"2006","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1016\/S0959-8049(02)00192-2","article-title":"Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest","volume":"38","author":"G Murillo","year":"2002","journal-title":"Eur J Cancer"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/jnci\/95.4.291","article-title":"Effects of deguelin on the phosphatidylinositol 3-kinase\/Akt pathway and apoptosis in premalignant human bronchial epithelial cells","volume":"95","author":"K-H Chun","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/sj.leu.2404788","article-title":"Deguelin inhibits expression of IkappaBalpha protein and induces apoptosis of B-CLL cells in vitro","volume":"21","author":"B Geeraerts","year":"2007","journal-title":"Leukemia"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1073\/pnas.85.19.7312","article-title":"Ly-1 B-cell clones similar to human chronic lymphocytic leukemias routinely develop in older normal mice and young autoimmune (New Zealand Black-related) animals","volume":"85","author":"AM Stall","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2141.2007.06851.x","article-title":"Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model","volume":"139","author":"BJ Scaglione","year":"2007","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"ref29","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1002\/cyto.b.20544","article-title":"The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia","volume":"78","author":"E Salerno","year":"2010","journal-title":"Cytometry B Clin Cytom"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"4133","DOI":"10.4049\/jimmunol.141.12.4133","article-title":"In vivo effects of hyperdiploid Ly-1+ B cells of NZB origin","volume":"141","author":"ES Raveche","year":"1988","journal-title":"J Immunol"},{"key":"ref31","first-page":"621","article-title":"Autoimmune reactions and malignant changes in New Zealand black mice","volume":"4","author":"J East","year":"1969","journal-title":"Clin Exp Immunol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1751-553X.2008.01030.x","article-title":"Prognostic irrelevance of HLA-G in B-cell chronic lymphocytic leukemia","volume":"31","author":"G Perez-Chacon","year":"2009","journal-title":"Int J Lab Hematol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1080\/10428190410001710812","article-title":"Routine analysis of IgVH mutational status in CLL patients using BIOMED-2 standardized primers and protocols","volume":"45","author":"C Matthews","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"JJM Van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.leukres.2006.03.021","article-title":"CD5 provides viability signals to B cells from a subset of B-CLL patients by a mechanism that involves PKC","volume":"31","author":"G Perez-Chacon","year":"2007","journal-title":"Leuk Res"},{"key":"ref36","first-page":"17","article-title":"IMGT-ONTOLOGY for immunogenetics and immunoinformatics","volume":"4","author":"M-P Lefranc","year":"2004","journal-title":"In Silico Biol"},{"key":"ref37","first-page":"1053","article-title":"TNFR-associated factor 2 deficiency in B lymphocytes predisposes to chronic lymphocytic leukemia\/small lymphocytic lymphoma in mice","volume":"189","author":"G P\u00e9rez-Chac\u00f3n","year":"2012","journal-title":"J Immunol Baltim Md"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1182\/blood.V85.7.1903.bloodjournal8571903","article-title":"CD40 ligand triggered interleukin-6 secretion in multiple myeloma","volume":"85","author":"M Urashima","year":"1995","journal-title":"Blood"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.58.3.10","article-title":"Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies","volume":"58","author":"T-C Chou","year":"2006","journal-title":"Pharmacol Rev"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"5079","DOI":"10.1182\/blood-2007-02-071225","article-title":"Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice","volume":"109","author":"ES Raveche","year":"2007","journal-title":"Blood"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"F Faul","year":"2007","journal-title":"Behav Res Methods"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"4441","DOI":"10.1182\/blood-2009-07-233718","article-title":"Diverse marrow stromal cells protect CLL cells from spontaneous and drug-induced apoptosis: development of a reliable and reproducible system to assess stromal cell adhesion-mediated drug resistance","volume":"114","author":"AV Kurtova","year":"2009","journal-title":"Blood"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/sj.leu.2403398","article-title":"A sustained activation of PI3K\/NF-kappaB pathway is critical for the survival of chronic lymphocytic leukemia B cells","volume":"18","author":"S Cun\u00ed","year":"2004","journal-title":"Leukemia"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/1476-4598-9-115","article-title":"Determination of genes and microRNAs involved in the resistance to fludarabine in vivo in chronic lymphocytic leukemia","volume":"9","author":"E Moussay","year":"2010","journal-title":"Mol Cancer"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"525","DOI":"10.18632\/oncotarget.491","article-title":"The Hsp90 inhibitor NVP-AUY922-AG inhibits NF-\u03baB signaling, overcomes microenvironmental cytoprotection and is highly synergistic with fludarabine in primary CLL cells","volume":"3","author":"E Walsby","year":"2012","journal-title":"Oncotarget"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/pr301055y","article-title":"Hsp90 Inhibitor SNX-7081 Dysregulates Proteins Involved with DNA Repair and Replication and the Cell Cycle in Human Chronic Lymphocytic Leukemia (CLL) Cells","volume":"12","author":"Y Che","year":"2013","journal-title":"J Proteome Res"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"40981","DOI":"10.18632\/oncotarget.5715","article-title":"The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia","volume":"6","author":"KL Kaufman","year":"2015","journal-title":"Oncotarget"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.canlet.2015.02.026","article-title":"The role of heat shock proteins in cancer","volume":"360","author":"GD Lianos","year":"2015","journal-title":"Cancer Lett"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cell.2007.08.028","article-title":"Regulation of Tumor Cell Mitochondrial Homeostasis by an Organelle-Specific Hsp90 Chaperone Network","volume":"131","author":"BH Kang","year":"2007","journal-title":"Cell"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"39835","DOI":"10.1074\/jbc.M110.141580","article-title":"Hsp90 (Heat Shock Protein 90) Inhibitor Occupancy Is a Direct Determinant of Client Protein Degradation and Tumor Growth Arrest in Vivo","volume":"285","author":"B Tillotson","year":"2010","journal-title":"J Biol Chem"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1016\/S1470-2045(13)70169-4","article-title":"Inhibition of HSP90 molecular chaperones: moving into the clinic","volume":"14","author":"R Garcia-Carbonero","year":"2013","journal-title":"Lancet Oncol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"39858","DOI":"10.1074\/jbc.M206322200","article-title":"Akt Forms an Intracellular Complex with Heat Shock Protein 90 (Hsp90) and Cdc37 and Is Destabilized by Inhibitors of Hsp90 Function","volume":"277","author":"AD Basso","year":"2002","journal-title":"J Biol Chem"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/sj.leu.2402415","article-title":"Hsp-90-associated oncoproteins: multiple targets of geldanamycin and its analogs","volume":"16","author":"MV Blagosklonny","year":"2002","journal-title":"Leukemia"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1182\/blood-2005-03-1099","article-title":"ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia","volume":"106","author":"JE Castro","year":"2005","journal-title":"Blood"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 Molecular Chaperone Inhibitors: Are We There Yet?","volume":"18","author":"L Neckers","year":"2012","journal-title":"Clin Cancer Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.bmcl.2010.06.108","article-title":"Hsp90 inhibition: Elimination of shock and stress","volume":"20","author":"AS Duerfeldt","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.2010.08348.x","article-title":"The novel Hsp\u201090 inhibitor SNX7081 is significantly more potent than 17\u2010AAG against primary CLL cells and a range of haematological cell lines, irrespective of lesions in the TP53 pathway","volume":"151","author":"OG Best","year":"2010","journal-title":"Br J Haematol"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.bbamcr.2009.08.002","article-title":"Hsp90 transcriptionally and post-translationally regulates the expression of NDRG1 and maintains the stability of its modifying kinase GSK3\u03b2","volume":"1793","author":"VM Banz","year":"2009","journal-title":"Biochim Biophys Acta BBA\u2014Mol Cell Res"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1182\/blood-2014-10-607036","article-title":"Stromal cell-mediated glycolytic switch in CLL cells involves Notch-c-Myc signaling","volume":"125","author":"R Jitschin","year":"2015","journal-title":"Blood"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"e65113","DOI":"10.1371\/journal.pone.0065113","article-title":"Deguelin Action Involves c-Met and EGFR Signaling Pathways in Triple Negative Breast Cancer Cells","volume":"8","author":"R Mehta","year":"2013","journal-title":"PLoS ONE"},{"key":"ref61","first-page":"38","article-title":"Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma","author":"Tang","year":"2010","journal-title":"Int J Oncol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/0008-5472.CAN-11-1674","article-title":"Intracellular ATP Levels Are a Pivotal Determinant of Chemoresistance in Colon Cancer Cells","volume":"72","author":"Y Zhou","year":"2012","journal-title":"Cancer Res"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"16617","DOI":"10.1016\/S0021-9258(17)46267-3","article-title":"Termination of DNA synthesis by 9-beta-D-arabinofuranosyl-2-fluoroadenine. A mechanism for cytotoxicity","volume":"265","author":"P Huang","year":"1990","journal-title":"J Biol Chem"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"4771","DOI":"10.1182\/blood-2010-05-286500","article-title":"Autoimmune cytopenia in chronic lymphocytic leukemia: prevalence, clinical associations, and prognostic significance","volume":"116","author":"C Moreno","year":"2010","journal-title":"Blood"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1749-6632.1992.tb24658.x","article-title":"Genetic regulation of CD5+ B cells in autoimmune disease and in chronic lymphocytic leukemia","volume":"651","author":"T Shirai","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1258\/002367771781006564","article-title":"Life span of specified-pathogen-free (MRC category 4) mice and rats","volume":"5","author":"MF Festing","year":"1971","journal-title":"Lab Anim"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"e83830","DOI":"10.1371\/journal.pone.0083830","article-title":"The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells","volume":"8","author":"S Fiorcari","year":"2013","journal-title":"PloS One"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1182\/blood-2011-11-390989","article-title":"The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia","volume":"119","author":"MFM de Rooij","year":"2012","journal-title":"Blood"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1158\/1940-6207.CAPR-08-0237","article-title":"Liposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis","volume":"2","author":"JK Woo","year":"2009","journal-title":"Cancer Prev Res (Phila Pa)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0154159","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T22:17:28Z","timestamp":1718489848000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0154159"}},"subtitle":[],"editor":[{"given":"Spencer B.","family":"Gibson","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,4,21]]},"references-count":69,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,4,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0154159","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2016,4,21]]}}}